This article discusses research providing renewed reasons to revisit the utility of glutamatergic drugs for treating schizophrenia.

Cocaine use disorder remains a critical public health concern with limited treatment options. Astrocytes are increasingly recognized as active regulators of neurotransmission and are emerging as impor...

Molecular Psychiatry - Grin2a knockout in adolescent dopamine neurons disrupts prediction error signaling and produces a phenotype relevant to schizophrenia

The Trump administration has frozen roughly $200 million in National Science Foundation, National Institutes of Health and other federal agency-funded research at UCLA, citing allegations the school d...

In dynamic environments where stimuli predicting reward or punishment unexpectedly change, it is critical to flexibly update behavior while preserving…

Neuropsychopharmacology - Estrous cycle stage gates the effect of stress on reward learning

In the face of recent abrupt shifts in federal funding for education research, including large-scale terminations of National Science Foundation (NSF) research grant awards, we have developed a rap...

The Women’s Health Initiative has produced numerous influential findings

Administration officials pressured NIH to avoid clear advice from the agency’s own lawyers to restart grant funding now.

NIGMS supports basic research to understand biological processes and lay the foundation for advances in disease diagnosis, treatment, and prevention.